Tech Company Financing Transactions
Advanced Biohealing Funding Round
On 5/31/2007, Advanced Biohealing raised $4.5 million in Series C funding from CDIB Bioscience and Safeguard Scientifics.
Transaction Overview
Company Name
Announced On
5/31/2007
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series C
Investors
Safeguard Scientifics (Gary Kurtzman)
Proceeds Purpose
Proceeds from the additional financing will be used to continue to expand the market for Dermagraft, approved by the U.S. Food and Drug Administration (FDA) as a treatment for full-thickness diabetic foot ulcers. Funding will also support the Company's clinical trials program and business development activities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
36 Church Ln.
Westport, CT 06880
USA
Westport, CT 06880
USA
Phone
Website
Email Address
Overview
Advanced BioHealing (ABH) is a specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products for wound care. We are a privately held company with two approved products: Dermagraft and TransCyte.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Rakin
Chief Medical Officer
Jan Lessem
Chief Scientific Officer
Charles Hart
Controller
Marc Posel
Vice President
Therésa Dixon
Vice President
Dean Tozer
VP - Operations
Kathy McGee
VP - Sales
Keith O'Briant
Browse more venture capital transactions:
Prev: 5/31/2007: SproutIt venture capital transaction
Next: 5/31/2007: Oberon Media venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs